<DOC>
	<DOCNO>NCT00592579</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness provide 2-methoxyestradiol patient plateau phase relapse multiple myeloma . Information regard trough 2ME2 level also collect .</brief_summary>
	<brief_title>A Phase 2 Study With Panzem Patients With Relapsed Plateau Phase Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>2-methoxyestradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>1 . Have plateau phase ( patient previously treat least one conventional highdose chemotherapy currently therapy least 4 week consider stable disease ) relapse MM . Patients plateau phase must Mprotein concentration stable least 4 week prior registration . 2 . Be least 18 year age . 3 . Have monoclonal plasma cell marrow . 4. Mprotein great equal 1g/dL serum 200 mg monoclonal light chain 24hour urine protein electrophoresis . 5 . Have laboratory data specify : AST ALT &lt; 2.5 x upper limit normal ( ULN ) Alk phos &lt; 5.0 x ULN direct bilirubin &lt; 2 x ULN Creatinine &lt; 3.0 x ULN ANC great equal 750 cells/mm3 Platelets &gt; 25,000/mm3 Hemoglobin great equal 7.0g/dL 6 . Have life expectancy least 3 month 7 . Have ECOG performance status 0 , 1 , 2 8 . Women men child bear potential must agree use effective barrier contraceptive method study . 9 . Have ability understand reuirements study , provide write informed consent , abide study restriction , agree return require assessment . 1 . Be pregnant nursing . 2 . Have condition likely detrimentally affect regular follow . 3 . Have history myocardial infarction within last 3 month , angina pectoris/angina equivalent last 3 month , uncontrolled congestive heart failure . 4 . Have active infection 5 . Have major surgery within 21 day start 2ME2 administration 6 . Have additional uncontrolled serious medical psychiatric illness 7. active cancer addition MM within last 5 year ( exclude superficial skin cancer ) 8 . Have uncontrolled untreated active bleeding thrombotic disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>